comparemela.com
Home
Live Updates
Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into ... : comparemela.com
Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into ...
KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build
Related Keywords
United States
,
Kansas City
,
Kansas
,
Thomas Dalton
,
Matt Kreps
,
Peterj Werth
,
Darrow Associates
,
Nasdaq
,
Securities Exchange
,
Exchange Commission
,
Platform Technology
,
Werth Family Investment Associates
,
Cingulate Therapeutics Llc Ctx
,
Cingulate Inc
,
Precision Timed Release
,
Cingulate Therapeutics
,
Note Conversion Agreement
,
Pre Funded Warrants
,
Securities Act
,
Hyperactivity Disorder
,
Erosion Barrier Layer
,
Looking Statements
,
Securities Exchange Act
,
Annual Report
,
Public Relations
,
Region
,
comparemela.com © 2020. All Rights Reserved.